SUV39H1 and posterior cortical atrophy: Importantly, the clinical relevance of the aberrant SUV39H1 expression in PCa development was supported by immunohistochemistry staining of SUV39H1 and H3K9me2/3 in PCa tissue microarrays (Figures 2g–j).